Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
36,72 € ↓ −1,56 (−4,08%)
2026-06-02
DELAT PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionWealthspire Advisors, LLC
Latest Disclosed Ownership12,505 shares
Latest Disclosed Value $ 459,556
Wealthspire Advisors, LLC reports 19.07% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 1, 2026 - Wealthspire Advisors, LLC filed a 13F-HR form disclosing ownership of 12,505 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $394,533 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 15,452 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -19.07% during the quarter. The current value of the position is $459,184 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 12,505 -2,947 -19.07 460 -41.60 0.0036
2026-02-12 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 15,452 -13,936 -47.42 786 -51.78 0.0063
2025-11-14 2025-09-30 13F Novo Nordisk A COM 670100205 29,388 2,296 8.47 1,631 -12.79 0.0085
2025-08-11 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 27,092 1,208 4.67 1,870 4.01 0.0105
2025-05-09 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 25,884 13,009 101.04 1,797 62.33 0.0107
2025-02-04 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 12,875 -3,013 -18.96 1,107 -41.46 0.0110
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 15,888 6,843 75.66 1,892 46.48 0.0192
2024-08-08 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 9,045 -97 -1.06 1,291 10.06 0.0165
2024-05-06 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 9,142 1,261 16.00 1,174 43.93 0.0157
2024-02-07 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 7,881 -611 -7.20 815 5.57 0.0116
2023-11-06 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 8,492 5,143 153.57 772 42.70 0.0128
2023-08-01 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 3,349 209 6.66 542 8.42 0.0089
2023-05-09 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 3,140 -1,988 -38.77 500 -28.10 0.0086
2023-02-14 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 5,128 1,635 46.81 694 99.43 0.0126
2022-11-14 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 3,493 814 30.38 348 16.39 0.0073
2022-08-09 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 2,679 -50 -1.83 299 -1.32 0.0063
2022-05-09 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 2,729 -1,941 -41.56 303 -42.07 0.0068
2022-02-14 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 4,670 -297 -5.98 523 9.64 0.0116
2021-11-15 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 4,967 1,345 37.13 477 57.43 0.0099
2021-08-13 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 3,622 -1,716 -32.15 303 -15.83 0.0080
2021-05-17 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 5,338 385 7.77 360 4.05 0.0085
2021-02-16 2020-12-31 13F NOVO-NORDISK A S ADR 670100205 4,953 4,953 346 0.0103
2020-08-14 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 0 -17,856 -100.00 0 -100.00
2020-05-12 2020-03-31 13F NOVO-NORDISK A S ADR 670100205 17,856 17,856 1,075 0.0451
2019-05-07 2019-03-31 13F NOVO-NORDISK A S ADR 670100205 0 -1,001 -100.00 0 -100.00
2019-02-14 2018-12-31 13F NOVO-NORDISK A S ADR 670100205 1,001 1,001 46 0.0044
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.